HC Wainwright reissued their buy rating on shares of Celldex Therapeutics (NASDAQ:CLDX – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has ...

Analysts at B. Riley raised their Q1 2025 earnings per share estimates for Madrigal Pharmaceuticals in a research report issued on Thursday, February 27th. B. Riley analyst M. Mamtani now expects that ...

Ma Ya, a 25-year-old woman from Jiangsu province, left a lucrative biopharmaceutical career to pursue her passion for ...

The BioWorld Biopharmaceutical Index (BBI) ended 2024 down 2.24%, despite hitting a peak of 25.19% in late August. While it ...

A notable NIH reform rolled out by Trump was a $4 billion cut to overhead funding for biomedical research by reducing ...

Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based ...

Dasgupta left India in 1985 and moved to the US to pursue an undergraduate degree that allowed her to major in biochemistry ...

A Chinese woman made the unconventional decision to leave her lucrative job to pursue her passion for animals, becoming a ...

Cambridge-based Draper Labs is set to launch their NASA-funded CP-12 mission in 2026, racing Texas-based Firefly Aerospace to ...

Liver cancer in the Philippines holds a staggering mortality rate of 11.6 out of 100,000 individuals, compared to the global death rate of 7.8/100,000. This reflects the significant impact of liver ...

The Novato-based maker of biopharmaceutical treatments for rare diseases plans to release this year a new gene therapy for ...

Vilobelimab is being developed for various debilitating or life-threatening inflammatory indications, including a Phase 3 trial for pyoderma gangrenosum (PG). Vilobelimab has been granted orphan drug ...